UNAIDS Launches Gender Equality Plan, IAS Presents Research Agenda for HIV/AIDS among Women and Children

SUMMARY: In recognition of International Women's Day on March 8 (and leading up to National Women and Girls HIV/AIDS Awareness Day on March 10), UNAIDS has launched a 5-year initiative to address worldwide gender inequality and human rights violations, including sexual violence, that increase women's and girls' vulnerability to HIV/AIDS. In addition, the International AIDS Society (IAS) -- in conjunction with UNAIDS, UNICEF, and a dozen other leading public and private organizations -- have released a new research agenda designed to advance global responses to HIV among women and children.

Below are media announcements from UNAIDS and IAS describing the new initiatives.

The full UNAIDS Agenda for Action and IAS Consensus Statement are available online.

UNAIDS Takes Action to Empower Women and Girls to
Protect Themselves from HIV

UN to support civil society and governments to address gender inequalities and human rights violations that continue to put women and girls at risk of HIV infection.

New York/Geneva -- March 2, 2010 -- UNAIDS, together with celebrated artist and activist for women and HIV, Annie Lennox, has launched an Agenda for Accelerated Country Action for Women, Girls, Gender Equality and HIV (2010-2014), which has been developed to address gender inequalities and human rights violations that continue to put women and girls at risk of HIV infection.

The five-year action plan was launched at a high-level panel during the 54th meeting on the Commission on the Status of Women, being held in New York until 12 March. It calls on the UN system to support governments, civil society and development partners in reinforcing country actions to put women and girls at the centre of the AIDS response, ensuring that their rights are protected.

"Violence against women is unacceptable and must not be tolerated," said Michel Sidibé, UNAIDS Executive Director. "By robbing them of their dignity, we are losing the opportunity to tap half the potential of mankind to achieve the Millennium Development Goals. Women and girls are not victims, they are the driving force that brings about social transformation."

UNAIDS and partners will support the country roll-out of the Agenda for Action in pathfinder countries, including Liberia.

Annie Lennox underlined her unshakable commitment to the cause of women and girls affected by HIV.

"I believe we need a broad movement for change," she said. "The bottom-line for me is that, in essence, we are all the same. All human beings, wherever we are, have the basic right to be happy and healthy. I see this Agenda for Action as a great opportunity to bring the realities faced by many women and girls to the forefront and to call attention to the injustices faced by many women and girls, placing them at a bigger risk of HIV."

HIV is the leading cause of death and disease among women of reproductive age (15-49 years) worldwide.
In Southern Africa, HIV prevalence among young women aged 15-24 years is on average about three times higher than among men of the same age.
Up to 70 percent of women worldwide encounter violence. Experiencing violence hampers women's ability to negotiate safe sex.

As of December 2008, 33.4 million people were living with HIV worldwide, of which 15.7 million -- almost half -- were women. The proportion of women infected with HIV has risen in many regions over of the world over the past 10 years. In sub-Saharan Africa, 60% of people living with HIV are women. Nearly 30 years into the HIV epidemic, HIV services do not sufficiently address the specific realities and needs of women and girls.

"The information on sexual and reproductive health for HIV-positive women and girls is still limited," said Suksma Ratri, a member of Indonesia's Positive Women's Network, who participated in today's launch. "Being sexually active and HIV-positive at the same time is very difficult. Women and girls living with HIV often have restricted options when it comes to their sexuality. They need an adequate and friendly support system that enables them to make free decisions about their sexuality without being discriminated and stigmatized. I think the Agenda for Action will be a good platform for countries to strengthen services for women and girls."

The Agenda for Action provides clear action points on how the UN can work together with governments, civil society and development partners to:

produce better information on the specific needs of women and girls in the context of HIV;
turn political commitments into increased resources and actions so HIV programs can better respond to the needs of women and girls; and
support leaders to build safer environments in which women's and girl's human rights are protected.

The actions include:

Improving data collection and analysis to better understand how the epidemic affects women and girls.

Reinforcing the UN Secretary-General's UNiTE to End Violence against Women campaign through the AIDS response.
Ensuring that violence against women is integrated into HIV prevention, treatment, care and support programs.
Analyzing the impact of socio-cultural and economic factors that prevent women and girls from protecting themselves against HIV.
Supporting women's groups and networks of women living with HIV to map commitments made by governments on women and HIV.
Scaling up engagement of men's and boys' organizations to support the rights of women and girls.

The launch of the Agenda for Action involved many prominent leaders from the United Nations system, governments and civil society. Speakers included Asha Rose Migiro, United Nations Deputy Secretary-General; Melanne Verveer, US Ambassador at Large for Women's Global Issues; Helen Clark, UNDP Administrator; and Vabah Gayflor, Liberia's Minister of Gender and Development.

UNAIDS

Leveraging the AIDS response, UNAIDS works to build political action and to promote the rights all of people for better results for global health and development. Globally, it sets policy and is the source of HIV-related data. In countries, UNAIDS brings together the resources of the UNAIDS Secretariat and 10 UN system organizations for coordinated and accountable efforts to unite the world against AIDS.

For more information, see www.unaids.org.



Expert Panel Releases Comprehensive New Research Agenda to Improve HIV Responses for Women and Children

On International Women's Day, IAS-Convened Panel Seeks Significant New Focus on Women and Children, Who Make Up the Majority of People Living with HIV Worldwide.

Geneva, Switzerland -- March 8, 2010 -- As the HIV pandemic continues to exact an increasing toll on women and children, the International AIDS Society (IAS) and 15 other leading public and private sector organizations have released a comprehensive new research agenda designed to significantly advance global responses to HIV in women and children. The new consensus statement, Asking the Right Questions: Advancing an HIV Research Agenda for Women and Children, includes 20 specific recommendations to expand and improve responses to the HIV-related challenges facing women and children worldwide.

The Agenda, which focuses on key gaps in clinical and programmatic knowledge that hinder access to effective HIV prevention, treatment and care for women and children, is being released today to coincide with International Women's Day, whose theme is "Equal Rights, Equal Opportunities: Progress for All."

Inadequate responses to HIV are a major barrier to women's health and progress worldwide. According to UNAIDS, 15.7 million women and 2.1 million children under age 15 were living with HIV in 2008. Women and children made up the majority of the estimated 33.4 million people living with HIV in 2008.

"HIV is the leading cause of death among women of reproductive age, and the leading cause of child death in many African countries, yet women and children are often either overlooked completely or folded into general responses to HIV," said IAS Executive Director Robin Gorna. "This agenda defines priority research needed to greatly improve our knowledge about and capacity to prevent and treat HIV in women and children. Implementation of this research agenda is key to closing these knowledge and service gaps, and to saving women's and children's lives."

The Agenda was developed through an extensive consultative process involving investigators, clinicians, civil society and UN agencies, and was informed by an expert-led mapping exercise and literature review initiated by the IAS' Industry Liaison Forum (IAS-ILF). In addition to the IAS, the consensus statement is endorsed by multilateral institutions, international civil society organizations and pharmaceutical industry leaders, including: amfAR, The Foundation for AIDS Research; AVAC, Global Advocacy for HIV Prevention; Boehringer Ingelheim; Clinton Health Access Initiative (CHAI); Coalition on Children Affected by AIDS (CCABA); E lizabeth Glaser Pediatric AIDS Foundation (EGPAF); European AIDS Treatment Group (EATG); International Community of Women Living with HIV/AIDS (ICW); International Treatment Preparedness Coalition (ITPC); Merck; Treatment Action Group (TAG); UNAIDS; UNICEF; ViiV Healthcare and WHO.

The Agenda identifies priority research questions within four broad categories: 1) clinical research on prevention of mother-to-child transmission (PMTCT) and paediatric treatment; 2) clinical research on treatment issues for women; 3) operations research for women; and 4) operations and implementation research related to PMTCT, including paediatric care, treatment and support. Recommendations in the fourth part of the agenda were developed through a parallel initiative led by UNICEF.

The Agenda outlines strategies to address issues such as:

Barriers to developing pediatric formulations of HIV treatments
The impact of interventions for TB, malaria and malnutrition on antiretroviral ARV) dosage
The impact of in utero exposure to antiretrovirals on uninfected children
Optimal weight-adapted parameters for antiretroviral therapy (ART) initiation and discontinuation in children
The impact of female hormone changes on treatment outcomes for women and adolescent girls
The impact of periodic ARV exposure via vertical transmission prophylaxis on future maternal treatment options
Barriers to ART access for women and girls.

The report recommends increased investment in research to address these challenges, greatly expanded sharing of data from existing studies related to HIV and women and children, and intensified efforts to disaggregate clinical data by sex to ensure opportunities for gender-based analysis. The endorsing organizations also call for collaboration between funders, researchers, health care providers, UN agencies and civil society and diagnostic and pharmaceutical industry in implementing the new research agenda.

"While substantial progress has been made in expanding access to antiretroviral therapy for adults and children and preventing vertical transmission of HIV, there is still far too much we do not know about preventing, managing and treating HIV disease in women and children," said Robin Gorna. "Only by working together to implement this research agenda can we rectify persistent inequities in clinical knowledge, achieve the Millennium Development Goals and prevent the needless illness and death of millions of women and children worldwide."

The full research agenda on women and children and detailed information on the iterative process used to develop, validate and prioritize the research priorities is available online at www.iasociety.org/ilf.aspx. Information on the UNICEF-led initiative, including the final list of operations/implementation research recommendations for PMTCT and pediatric care, treatment and support from a September 2009 expert consultation held in Washington, will be available online at www.unicef.org or www.pedaids.org.

About the IAS

The International AIDS Society (IAS) is the world's leading independent association of HIV professionals, with 14,000 members from 190 countries working at all levels of the global response to AIDS. Our members include researchers from all disciplines, clinicians, public health and community practitioners on the frontlines of the epidemic, as well as policy and program planners. The IAS is the custodian of the biennial International AIDS Conference, which will next be held in Vienna, Austria, in July 2010.

The IAS-Industry Liaison Forum, established in 2001, provides a multi-stakeholder forum that promotes scientific, intellectual and financial commitments from pharmaceutical and diagnostic companies for HIV research in resource-limited settings.

3/9/10

Sources

UNAIDS. UNAIDS Takes Action to Empower Women and Girls to Protect Themselves from HIV. Press release. March 2, 2010.

International AIDS Society. Expert Panel Releases Comprehensive New Research Agenda to Improve HIV Responses for Women and Children. Press release. March 8, 2010.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 Google Custom Search
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children